Citation Impact
Citing Papers
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Activators and target genes of Rel/NF-κB transcription factors
1999 Standout
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
2013 Standout
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
1993
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Standard and low-dose chemotherapy for the treatment of myelodysplastic syndromes
1998
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
A predictive model for the clinical response to low dose ara‐C: a study of 102 patients with myelodysplastic syndromes or acute leukaemia
1992
Radiation-induced lung injury
2003
Cisplatin, ifosfamide and vindesine in the chemotherapy of non-small-cell lung cancer: a combination phase II study
1990 StandoutNobel
Amifostine
2001
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Drug development from marine natural products
2008 Standout
Effect of pegylation on pharmaceuticals
2003 Standout
Systematic review of amifostine for the management of oral mucositis in cancer patients
2012
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2014 Standout
Bone marrow autotransplantation
1989
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.
1988
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer
2010
Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
1988
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
2007
Effects of Amifostine on Radiation-induced Cardiac Damage
2003
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Radioprotection of Lungs by Amifostine is Associated with Reduction in Profibrogenic Cytokine Activity
2002
Salvage Therapy for Refractory or Relapsed Acute Lymphocytic Leukemia
2001
The pathobiology of mucositis
2004 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Analysis of anticancer drugs: A review
2011 Standout
Oxidative Stress in Cancer
2020 Standout
Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
2001
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Hyperleukocytosis, leukostasis and leukapheresis: Practice management
2012
Clinical Pharmacology of 5-Fluorouracil
1989 Standout
Mucosal injury in patients undergoing hematopoietic progenitor cell transplantation: new approaches to prophylaxis and treatment
2003
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies
2011
Detection and determination of the major metabolites of [3H]cytosine arabinoside by high-performance liquid chromatography
1996
Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized Study
2003
Has the outlook improved for amifostine as a clinical radioprotector?
2000
Cancer of the Ovary
2004 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Prognostic value of S‐phase cells in AML patients
1995
Antineoplastic Drugs
1978
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Binding of the aminothiol WR-1065 to transcription factors influences cellular response to anticancer drugs.
2001
Eye toxicity of cancer chemotherapy: A review of the literature
1981
Hyperleukocytosis and leukostasis: management of a medical emergency
2016
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
2003
Childhood and adolescent cancer statistics, 2014
2014 Standout
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar)
1999
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
A Potential Synergistic Anticancer Effect of Paclitaxel and Amifostine on Endometrial Cancer
2005
Amifostine: chemotherapeutic and radiotherapeutic protective effects
2001
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Mechanisms of Cancer Drug Resistance
2002 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
1987 StandoutNobel
1-beta-D-Arabinofuranosylcytosine stimulates ceramide and diglyceride formation in HL-60 cells.
1994
Treatment of the Newly Diagnosed Adult with De Noyo Acute Myeloid Leukemia
1993
Bone Marrow Transplant
1990 Standout
New agents in non-small cell lung cancer
1984
Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
2002
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study
1996
Treatment of the newly diagnosed adult with de novo acute myeloid leukemia.
1993
Cisplatin
1984 Standout
Works of Capizzi Rl being referenced
S-phase fraction is not correlated with nucleoside transport in acute myeloid leukemia cells.
1991
The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.
1999
Clinical status and optimal use of amifostine.
1999
The pharmacologic basis for the efficacy of high-dose Ara-C and sequential asparaginase in adult acute myelogenous leukemia.
1988
Low dose Ara-C for patients with myelodysplastic syndromes.
1988
Cancer and leukemia group B phase II non-small cell lung carcinoma trial: aziridinylbenzoquinone (AZQ).
1983
Combination chemotherapy--theory and practice.
1977
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase.
1984
Phase I trials of high-dose cytosine arabinoside (HDara-C) and HDara-C plus cisplatin in patients with advanced malignancies.
1985
Leukapheresis induced changes in cell cycle distribution and nucleoside transporters in patients with untreated acute myeloid leukemia.
1991